Nutriband, Inc. (NTRB)
7.28
-0.08
(-1.09%)
USD |
NASDAQ |
Oct 02, 16:00
7.50
+0.22
(+3.02%)
After-Hours: 20:00
Nutriband Net Income (Quarterly) : -0.8806M for July 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.8806M |
| April 30, 2026 | -1.242M |
| January 31, 2026 | -0.9681M |
| October 31, 2025 | -3.872M |
| July 31, 2025 | -2.000M |
| April 30, 2025 | -1.389M |
| January 31, 2025 | -5.516M |
| October 31, 2024 | -1.363M |
| July 31, 2024 | -1.706M |
| April 30, 2024 | -1.898M |
| January 31, 2024 | -1.881M |
| October 31, 2023 | -1.760M |
| July 31, 2023 | -0.8292M |
| April 30, 2023 | -1.015M |
| January 31, 2023 | -1.679M |
| October 31, 2022 | -1.076M |
| July 31, 2022 | -1.039M |
| April 30, 2022 | -0.69M |
| January 31, 2022 | -3.768M |
| October 31, 2021 | -1.572M |
| July 31, 2021 | -0.5199M |
| April 30, 2021 | -0.3151M |
| Date | Value |
|---|---|
| January 31, 2021 | -2.252M |
| October 31, 2020 | -0.0426M |
| July 31, 2020 | -0.2259M |
| April 30, 2020 | -0.4122M |
| January 31, 2020 | -0.9444M |
| October 31, 2019 | -0.7533M |
| July 31, 2019 | -0.4506M |
| April 30, 2019 | -0.5734M |
| January 31, 2019 | -0.5158M |
| October 31, 2018 | -0.4886M |
| July 31, 2018 | -1.879M |
| April 30, 2018 | -0.4481M |
| January 31, 2018 | -2.436M |
| October 31, 2017 | -0.1077M |
| July 31, 2017 | -0.093M |
| April 30, 2017 | -0.0356M |
| January 31, 2017 | -0.0336M |
| October 31, 2016 | -0.03M |
| July 31, 2016 | -0.0356M |
| April 30, 2016 | -0.0521M |
| January 31, 2016 | -0.0004M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.4375M |
| Total Expenses (Quarterly) | 1.318M |
| EPS Diluted (Quarterly) | -0.0724 |
| Enterprise Value | 85.29M |
| Gross Profit Margin (Quarterly) | 40.73% |
| Profit Margin (Quarterly) | -201.3% |
| Earnings Yield | -7.90% |
| Normalized Earnings Yield | -7.904 |